Davis Joseph, Director of Biochemistry at FLOGEN Technologies in Canada and Research Associate at Gifu University in Japan, delivered a scientific presentation at the 7th Annual Meeting of the Japanese Society for Brain Supplements on October 25, 2025, in Kitakyushu,Japan.

His talk, titled 'Uncovering the Core Neurobiological Mechanism Behind 4E-BP2 Deamidation and Its Role in Neurodegenerative Disease,' explored a newly identified pathway that may reshape how researchers understand brain disorders.

Joseph highlighted how neuron-specific deamidation of the 4E-BP2 protein influences key processes such as translational regulation, oxidative stress responses, and overall neuronal function. By connecting these molecular events to the progression of neurodegenerative conditions, he outlined how this mechanism could open new directions for therapeutic development.

The presentation offered a detailed look at how subtle biochemical modifications can have far-reaching consequences for brain health, emphasizing the importance of molecular precision in understanding -and eventually treating- neurodegenerative diseases.

Dr. Davis Joseph, Director of Biochemistry at FLOGEN Technologies and Research Associate at Gifu University, presenting at the 7th Annual Meeting of the Japanese Society of Brain Supplements, Kitakyushu, Japan, October 25, 2025